Literature DB >> 7559945

Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction.

G J van Doornum1, M Buimer, M Prins, C J Henquet, R A Coutinho, P K Plier, S Tomazic-Allen, H Hu, H Lee.   

Abstract

The suitability of urine specimens from women and men for the detection of Chlamydia trachomatis infection by a ligase chain reaction (LCR)-based assay with plasmid primers was examined with a group of patients attending a sexually transmitted disease clinic in Amsterdam, The Netherlands. Cervical specimens from 15 of 237 (6.3%) women tested positive for C. trachomatis by cell culture. Of the 25 (10.5%) female urine samples that tested positive by the plasmid-LCR assay, 13 were obtained from cervical culture-positive women. Nine of the 12 plasmid-LCR-positive urine samples from cervical culture-negative women were confirmed to be positive by a second LCR assay with primers based on chromosomal DNA. Urethral specimens from 24 of 258 (9.3%) men were positive for C. trachomatis infection by cell culture. Of the 25 (9.7%) urine samples that tested positive by plasmid-LCR, 20 were from culture-positive men. All five of the LCR-positive urine samples from culture-negative men were confirmed to be positive by the LCR with chromosomal DNA primers. Relative to cell culture, testing by plasmid-LCR analysis of male urine samples had a sensitivity of 83.3% and a specificity of 97.9%; after resolution of discordant samples, these values were 86.2 and 100%, respectively. In the study with women, the sensitivities of plasmid-LCR analysis of cervical and urine specimens in comparison with cervical cell culture were 93.3 and 86.7%, respectively. After resolution of discrepant samples, the sensitivities of the plasmid-LCR test for cervical swabs and female urine samples were 96.3 and 92.6%, respectively. These results indicate that the plasmid-LCR-based assay is a very reliable, sensitive, convenient test for the detection of C. trachomatis infection in female and male urine specimens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559945      PMCID: PMC228332          DOI: 10.1128/jcm.33.8.2042-2047.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow?

Authors:  J Schachter; W E Stamm; M A Chernesky; E W Hook; R B Jones; F N Judson; J A Kellogg; B LeBar; P A Mårdh; W M McCormack
Journal:  Sex Transm Dis       Date:  1992 Sep-Oct       Impact factor: 2.830

2.  Comparison of plasmid- and chromosome-based polymerase chain reaction assays for detecting Chlamydia trachomatis nucleic acids.

Authors:  J B Mahony; K E Luinstra; J W Sellors; M A Chernesky
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

3.  Evaluation of the Amplicor Chlamydia trachomatis test versus culture in genital samples in various prevalence populations.

Authors:  B de Barbeyrac; I Pellet; B Dutilh; C Bébéar; B Dumon; M Géniaux; C Bébéar
Journal:  Genitourin Med       Date:  1994-06

4.  Amplification of Chlamydia trachomatis DNA by ligase chain reaction.

Authors:  B J Dille; C C Butzen; L G Birkenmeyer
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

5.  Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens.

Authors:  C A Bass; D L Jungkind; N S Silverman; J M Bondi
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

6.  Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine.

Authors:  J E Bauwens; A M Clark; M J Loeffelholz; S A Herman; W E Stamm
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

7.  Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay.

Authors:  J E Bauwens; A M Clark; W E Stamm
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

8.  Development and clinical evaluation of a polymerase chain reaction test for detection of Chlamydia trachomatis.

Authors:  J M Ossewaarde; M Rieffe; M Rozenberg-Arska; P M Ossenkoppele; R P Nawrocki; A M van Loon
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

9.  Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study.

Authors:  G J Van Doornum; M Prins; L H Juffermans; C Hooykaas; J A van den Hoek; R A Coutinho; W G Quint
Journal:  Genitourin Med       Date:  1994-08

10.  Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay.

Authors:  G Jaschek; C A Gaydos; L E Welsh; T C Quinn
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

View more
  27 in total

Review 1.  Strategies for signal amplification in nucleic acid detection.

Authors:  S C Andras; J B Power; E C Cocking; M R Davey
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

2.  Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.

Authors:  W H Goessens; J W Mouton; W I van der Meijden; S Deelen; T H van Rijsoort-Vos; N Lemmens-den Toom; H A Verbrugh; R P Verkooyen
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Effect of urine specimen dilution on the performance of two commercial systems in the detection of Chlamydia trachomatis infection in men.

Authors:  R Pasternack; P Vuorinen; A Miettinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

4.  False-negative results of a ligase chain reaction assay to detect Chlamydia trachomatis due to inhibitors in urine.

Authors:  E S Berg; G Anestad; H Moi; G Størvold; K Skaug
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

5.  An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance.

Authors:  M Rosenstraus; Z Wang; S Y Chang; D DeBonville; J P Spadoro
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 6.  Is Europe ready for STD screening?

Authors:  P A Mårdh
Journal:  Genitourin Med       Date:  1997-04

7.  Differences in the sensitivity of the Amplicor Chlamydia trachomatis PCR assay.

Authors:  J M Ossewaarde; G J van Doornum; M Buimer; B Choueiri; A Stary
Journal:  Genitourin Med       Date:  1997-06

8.  Evaluation of 2-SP transport medium for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by two automated amplification systems and culture for chlamydia.

Authors:  O Dubuis; M Gorgievski-Hrisoho; D Germann; L Matter
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

9.  Use of ligase chain reaction with urine versus cervical culture for detection of Chlamydia trachomatis in an asymptomatic military population of pregnant and nonpregnant females attending Papanicolaou smear clinics.

Authors:  C A Gaydos; M R Howell; T C Quinn; J C Gaydos; K T McKee
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

10.  Follow-up, treatment, and reinfection rates among asymptomatic chlamydia trachomatis cases in general practice.

Authors:  Irene G M van Valkengoed; Servaas A Morré; Adriaan J C van den Brule; Chris J L M Meijer; Lex M Bouter; Jacques Th M van Eijk; A Joan P Boeke
Journal:  Br J Gen Pract       Date:  2002-08       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.